We assessed whether prostate cancer screening would decrease prostate cancer mortality in white men with a family history of prostate cancer.Data from the PLCO cancer screening trial were used to compare the screening and usual care arms in the subset of men with and without a family history of prostate cancer. Univariate and multivariate Cox regression analysis, and log rank analysis of Kaplan-Meier curves were done to examine the data for differences in prostate cancer specific survival.A total of 65,179 white subjects were included in the prostate specific antigen screening trial, of whom 7,314 (11.2

作者：Michael A, Liss；Haitao, Chen；Sij, Hemal；Spencer, Krane；Christopher J, Kane；Jianfeng, Xu；A Karim, Kader

来源：The Journal of urology 2015 年 193卷 1期